Prolonged hematopoietic and myeloid cellular response in patients after an acute coronary syndrome measured with (18)F-DPA-714 PET/CT.
Prolonged hematopoietic and myeloid cellular response in patients after an acute coronary syndrome measured with (18)F-DPA-714 PET/CT.
复制标题
DOI:
10.1007/s00259-018-4038-8
复制
发表时间:
2018-10
影响因子:
9.1
通讯作者:
Stroes ESG
中科院分区:
文献类型:
--
作者:
Verweij SL;Stiekema LCA;Delewi R;Zheng KH;Bernelot Moens SJ;Kroon J;Stroes CI;Versloot M;Piek JJ;Verberne HJ;Stroes ESG
An acute coronary syndrome (ACS) is characterized by a multi-level inflammatory response, comprising activation of bone marrow and spleen accompanied by augmented release of leukocytes into the circulation. The duration of this response after an ACS remains unclear. Here, we assessed the effect of an ACS on the multi-level inflammatory response in patients both acutely and after 3 months. We performed 18F-DPA-714 PET/CT acutely and 3 months post-ACS in eight patients and eight matched healthy controls. DPA-714, a PET tracer binding the TSPO receptor and highly expressed in myeloid cells, was used to assess hematopoietic activity. We also characterized circulating monocytes and hematopoietic stem and progenitor cells (HSPCs) by flow cytometry in 20 patients acutely and 3 months post-ACS and in 19 healthy controls. In the acute phase, patients displayed a 1.4-fold and 1.3-fold higher 18F-DPA-714 uptake in, respectively, bone marrow (p = 0.012) and spleen (p = 0.039) compared with healthy controls. This coincided with a 2.4-fold higher number of circulating HSPCs (p = 0.001). Three months post-ACS, 18F-DPA-714 uptake in bone marrow decreased significantly (p = 0.002), but no decrease was observed for 18F-DPA-714 uptake in the spleen (p = 0.67) nor for the number of circulating HSPCs (p = 0.75). 18F-DPA-714 PET/CT reveals an ACS- triggered hematopoietic organ activation as initiator of a prolonged cellular inflammatory response beyond 3 months, characterized by a higher number of circulating leukocytes and their precursors. This multi-level inflammatory response may provide an attractive target for novel treatment options aimed at reducing the high recurrence rate post-ACS. The online version of this article (10.1007/s00259-018-4038-8) contains supplementary material, which is available to authorized users.
登录
查看更多内容
DOI:
10.1177/0271678x17710182
发表时间:
2017-08
期刊:
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
影响因子:
--
作者:
Owen DR;Narayan N;Wells L;Healy L;Smyth E;Rabiner EA;Galloway D;Williams JB;Lehr J;Mandhair H;Peferoen LA;Taylor PC;Amor S;Antel JP;Matthews PM;Moore CS
通讯作者:
Moore CS
DOI:
10.1089/scd.1.1996.5.213
发表时间:
1996-06-01
期刊:
Journal of hematotherapy
影响因子:
--
作者:
Sutherland, D R;Anderson, L;Chin-Yee, I
通讯作者:
Chin-Yee, I
影响因子:
39.3
作者:
Gaemperli, Oliver;Shalhoub, Joseph;Camici, Paolo G.
通讯作者:
Camici, Paolo G.
DOI:
10.1161/circimaging.113.001093
发表时间:
2014-05-01
期刊:
Circulation. Cardiovascular imaging
影响因子:
--
作者:
Kim, Eung Ju;Kim, Sungeun;Seo, Hong Seog
通讯作者:
Seo, Hong Seog
影响因子:
14.5
作者:
Hamelin, Lorraine;Lagarde, Julien;Sarazin, Marie
通讯作者:
Sarazin, Marie